Press Releases

• Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group, acquires JSS Medical Research to expand its clinical services portfolio.
• Genesis Axis Acquires Organochem to Grow the Preclinical Chemistry Services Portfolio.
• Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)
• Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add “off the shelf” PK profiling capabilities to its portfolio
• Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
• Genesis Biotechnology Group announces second year of CRO relationship with Yale University
• Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development
• Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer
• Genesis Biotechnology Group Appoints Erich E. Dagnal as Director of Mergers & Acquisitions
• Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
• Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima
• Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development (GD3)
• Genesis Biotechnology Group® (GBG) Announces First Annual Community Fall Fest in Hamilton
• Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma
• Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
• Genesis Biotechnology Group announces partnership with Yale University
• Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
• Abstract accepted for Presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting April 29 - May 03, 2018 in Honolulu, Hawaii
• 3/1/2018 STATKING Promotes Two Employees to Director Level
• 11/18/2014 STATKING Clinical Services Reaches 25 Year Milestone
• 7/2/2012 STATKING Programmers Earn Certifications
• 1/19/2012 STATKING Signs Agreement to Provide Webinar Content
• 12/15/2011 STATKING Statisticians Involved in Poster On Development of Cancer Diagnostic Test
• 08/20/2011 STATKING Provides Clinical Services Support for Radiopharmaceutical
• 05/24/2011 STATKING Provides Clinical Services Support for Women’s Health Drug
• 05/17/2011 STATKING Statistician Receives Professional Accreditation
• 03/30/2011 STATKING is Now STATKING Clinical Services
• 02/10/2010 STATKING Expands Electronic Data Capture Support
• 07/01/2008 STATKING Announces Staffing Changes
• 12/30/2008 STATKING Announces Hiring of Hussein Al-Khalidi as Director of Biostatistics
• 11/26/2007 STATKING Expands with the Opening of St Louis Office
• 10/19/2007 STATKING Expands Headquarters by Purchasing Additional Office Space
• 05/09/2007 STATKING Completes Expansion of Headquarters and Adds Safeguards for Document Storage
• 05/01/2005 STATKING Expands Headquarters to Accommodate Larger Clinical Trials
• 06/15/2004 Roderick L Lashley Becomes Partner in SCI
• 03/16/2004 STATKING Expands Again
• 04/16/2004 STATKING Signs Alliance Agreement with Regulatory Affairs Group
• 08/20/2001 STATKING President Receives Alumni Award
• 03/12/2000 STATKING Serves First Client in Australia
• 02/02/1998 STATKING Buys Office Space
• 10/15/1995 Dr King’s Book Published by SAS Institute Inc
• 10/20/1993 Dr King Signs Publishing Agreement with SAS Institute Inc